Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Up 38.0% in September

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 273,700 shares, a growth of 38.0% from the August 31st total of 198,300 shares. Approximately 2.2% of the company’s stock are short sold. Based on an average daily volume of 4,630,000 shares, the short-interest ratio is currently 0.1 days.

Autonomix Medical Stock Up 2.4 %

Shares of NASDAQ AMIX traded up $0.01 during mid-day trading on Friday, reaching $0.60. 31,618 shares of the company were exchanged, compared to its average volume of 1,849,576. Autonomix Medical has a 1 year low of $0.51 and a 1 year high of $7.60. The firm has a 50-day moving average of $0.79 and a 200 day moving average of $1.73. The company has a current ratio of 9.27, a quick ratio of 9.27 and a debt-to-equity ratio of 0.20.

Autonomix Medical (NASDAQ:AMIX) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($0.14) earnings per share for the quarter. On average, equities analysts predict that Autonomix Medical will post -0.5 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, LADENBURG THALM/SH SH started coverage on shares of Autonomix Medical in a research report on Tuesday, September 3rd. They issued a “buy” rating and a $1.40 price target for the company.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.